ATYR — ATYR PHARMA INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 96 家机构在其最新 13F 申报中持有 ATYR(ATYR PHARMA INC),合计申报市值 $23.57M,对应 39.37M 股。按股数计算较上季度减持 33.5%(-17.92M 股),申报市值环比下降 49.1%。持仓集中度较高:前五大持有人占申报市值的 53.2%,前十大的集中度为 75.9%。
与上一季度相比,19 家新建仓位、31 家加仓、31 家减仓、39 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
ATYR PHARMA INC(ATYR)的主要机构持有人包括 Octagon Capital Advisors LP、Rosalind Advisors, Inc.、Alyeska Investment Group, L.P.,按 13F 申报市值在本页 253 家持有人中排名居前。
ATYR 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 53 | 20.22M | $6.14M | -25.0% |
| Q2 2026 | 96 | 39.37M | $23.57M | -33.5% |
| Q1 2026 | 116 | 57.60M | $44.89M | +2.0% |
| Q4 2025 | 90 | 55.14M | $55.93M | -8.4% |
| Q3 2025 | 122 | 71.99M | $55.24M | +11.3% |
| Q2 2025 | 118 | 67.09M | $339.14M | +7.5% |
| Q1 2025 | 90 | 61.39M | $185.41M | +14.1% |
| Q4 2024 | 77 | 54.47M | $197.17M | -0.3% |
表内 8 个季度中,机构持股合计减少 63%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2026(-33.5%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.97M | $1.50M | 0.00% | 减持 | |
| 3.76M | $1.14M | 0.00% | 减持 | |
| 1.83M | $554.34K | 0.42% | 增持 | |
| 1.78M | $539.68K | 0.00% | 减持 | |
| 1.62M | $491.02K | 0.00% | 减持 | |
| 1.21M | $365.74K | 0.00% | 增持 | |
| 1.17M | $353.33K | 0.00% | 减持 | |
| 1.10M | $333.53K | 0.00% | 减持 | |
| 576.12K | $174.57K | 0.00% | 持有 | |
| 481.95K | $146.03K | 0.00% | 减持 | |
| 400.83K | $121.45K | 0.00% | 新进 | |
| 319.67K | $95.90K | 0.00% | 减持 | |
| 281.52K | $85.30K | 0.00% | 增持 | |
| 105.00K | $31.82K | 0.00% | 新进 | |
| 96.38K | $29.20K | 0.00% | 增持 | |
| 60.80K | $18.42K | 0.00% | 新进 | |
| 52.00K | $15.76K | 0.00% | 持有 | |
| 50.00K | $15.38K | 0.01% | 持有 | |
| 48.11K | $14.58K | 0.00% | 减持 | |
| 35.99K | $10.90K | 0.00% | 持有 | |
| 33.41K | $10.12K | 0.00% | 持有 | |
| 28.12K | $8.52K | 0.00% | 持有 | |
| 26.69K | $8.09K | 0.00% | 减持 | |
| 23.60K | $7.15K | 0.00% | 增持 | |
| 20.62K | $6.25K | 0.00% | 减持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 8.51M | $5.08M | 0.01% | 减持 | |
| 3.81M | $2.27M | 0.00% | 持有 | |
| 3.45M | $2.06M | 0.13% | 增持 | |
| 2.61M | $1.56M | 0.00% | 增持 | |
| 2.61M | $1.56M | 0.00% | 增持 | |
| 2.47M | $1.47M | 0.00% | 减持 | |
| 1.83M | $1.09M | 0.00% | 减持 | |
| 1.79M | $1.07M | 0.61% | 新进 | |
| 1.53M | $914.10K | 0.00% | 减持 | |
| 1.34M | $801.88K | 0.00% | 增持 | |
| 1.25M | $743.10K | 0.00% | 增持 | |
| 1.18M | $702.73K | 0.00% | 新进 | |
| 1.18M | $702.73K | 0.00% | 减持 | |
| 656.05K | $391.53K | 0.00% | 减持 | |
| 656.05K | $391.53K | 0.00% | 减持 | |
| 641.21K | $382.67K | 0.00% | 增持 | |
| 576.12K | $343.95K | 0.00% | 减持 | |
| 368.12K | $220.87K | 0.00% | 增持 | |
| 190.00K | $185.39K | 0.02% | 新进 | |
| 226.68K | $135.28K | 0.00% | 增持 | |
| 220.14K | $131.38K | 0.00% | 减持 | |
| 207.47K | $123.65K | 0.00% | 减持 | |
| 165.22K | $98.60K | 0.00% | 增持 | |
| 150.67K | $85.34K | 0.00% | 增持 | |
| 127.00K | $75.79K | 0.00% | 新进 |
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 14.71M | $11.47M | 0.00% | 持有 | |
| 10.51M | $8.20M | 0.01% | 持有 | |
| 6.44M | $5.03M | 0.00% | 减持 | |
| 3.87M | $3.02M | 0.00% | 增持 | |
| 3.81M | $2.97M | 0.00% | 新进 | |
| 2.39M | $1.86M | 0.00% | 增持 | |
| 1.75M | $1.37M | 0.00% | 增持 | |
| 1.68M | $1.31M | 0.08% | 减持 | |
| 1.64M | $1.28M | 0.00% | 新进 | |
| 1.64M | $1.28M | 0.00% | 新进 | |
| 1.23M | $955.87K | 0.00% | 减持 | |
| 1.14M | $892.76K | 0.00% | 增持 | |
| 711.11K | $554.66K | 0.00% | 增持 | |
| 651.83K | $508.43K | 0.00% | 新进 | |
| 569.23K | $444.00K | 0.00% | 新进 | |
| 496.02K | $386.89K | 0.00% | 减持 | |
| 496.02K | $386.89K | 0.00% | 减持 | |
| 303.56K | $236.78K | 0.00% | 增持 | |
| 283.24K | $220.92K | 0.00% | 减持 | |
| 229.28K | $178.84K | 0.00% | 增持 | |
| 210.74K | $164.38K | 0.00% | 减持 | |
| 210.74K | $164.38K | 0.00% | 减持 | |
| 193.53K | $150.95K | 0.00% | 持有 | |
| 138.12K | $107.73K | 0.00% | 新进 | |
| 111.42K | $86.91K | 0.00% | 增持 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.04M | $13.60M | 5.44% | 减持 | |
| 14.70M | $11.51M | 0.00% | 持有 | |
| 10.51M | $8.23M | 0.01% | 持有 | |
| 6.55M | $5.13M | 0.00% | 增持 | |
| 4.96M | $3.89M | 0.00% | 减持 | |
| 2.63M | $2.06M | 0.18% | 增持 | |
| 2.28M | $1.79M | 0.00% | 增持 | |
| 1.72M | $1.35M | 0.00% | 减持 | |
| 1.63M | $1.27M | 0.00% | 减持 | |
| 1.40M | $1.10M | 0.00% | 增持 | |
| 841.35K | $658.86K | 0.00% | 新进 | |
| 769.82K | $602.85K | 0.00% | 新进 | |
| 769.82K | $602.85K | 0.00% | 新进 | |
| 702.19K | $549.88K | 0.00% | 增持 | |
| 460.83K | $360.88K | 0.10% | 持有 | |
| 454.44K | $355.87K | 0.00% | 增持 | |
| 345.59K | $270.63K | 0.00% | 减持 | |
| 227.94K | $178.50K | 0.00% | 持有 | |
| 221.77K | $173.67K | 0.00% | 减持 | |
| 221.77K | $173.67K | 0.00% | 减持 | |
| 193.53K | $151.56K | 0.00% | 减持 | |
| 181.97K | $142.50K | 0.00% | 减持 | |
| 174.18K | $136.40K | 0.00% | 减持 | |
| 148.10K | $115.52K | 0.00% | 增持 | |
| 127.20K | $99.61K | 0.00% | 减持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 14.70M | $10.60M | 0.00% | 增持 | |
| 10.54M | $7.61M | 0.01% | 减持 | |
| 6.47M | $4.67M | 0.00% | 增持 | |
| 1.57M | $4.47M | 1.86% | 增持 | |
| 5.63M | $4.06M | 0.00% | 增持 | |
| 4.51M | $3.25M | 0.00% | 增持 | |
| 4.20M | $3.03M | 0.00% | 增持 | |
| 2.18M | $1.57M | 0.00% | 增持 | |
| 2.10M | $1.51M | 0.15% | 新进 | |
| 1.89M | $1.36M | 0.00% | 增持 | |
| 1.89M | $1.36M | 0.00% | 增持 | |
| 1.25M | $901.25K | 0.13% | 新进 | |
| 710.34K | $512.44K | 0.00% | 增持 | |
| 706.73K | $510.00K | 0.04% | 增持 | |
| 688.16K | $496.44K | 0.00% | 增持 | |
| 674.12K | $486.31K | 0.00% | 减持 | |
| 671.13K | $484.16K | 0.02% | 持有 | |
| 658.00K | $474.68K | 0.04% | 新进 | |
| 600.00K | $432.84K | 0.32% | 增持 | |
| 568.90K | $410.40K | 0.00% | 新进 | |
| 510.00K | $367.91K | 0.01% | 新进 | |
| 500.00K | $360.70K | 0.00% | 新进 | |
| 460.83K | $332.44K | 0.10% | 减持 | |
| 438.26K | $316.16K | 0.00% | 新进 | |
| 414.73K | $299.19K | 0.00% | 增持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 14.67M | $74.36M | 0.14% | 持有 | |
| 13.35M | $67.69M | 0.00% | 增持 | |
| 5.78M | $29.32M | 0.00% | 增持 | |
| 4.66M | $23.60M | 0.00% | 增持 | |
| 3.82M | $19.37M | 4.25% | 增持 | |
| 2.46M | $12.48M | 5.64% | 持有 | |
| 2.10M | $10.64M | 0.00% | 增持 | |
| 1.75M | $8.85M | 0.01% | 增持 | |
| 1.68M | $8.53M | 0.04% | 持有 | |
| 1.65M | $8.37M | 0.00% | 增持 | |
| 1.41M | $7.16M | 0.03% | 增持 | |
| 1.24M | $6.29M | 0.00% | 增持 | |
| 1.05M | $5.32M | 0.50% | 增持 | |
| 988.68K | $5.01M | 0.03% | 减持 | |
| 680.94K | $3.45M | 0.00% | 增持 | |
| 671.13K | $3.40M | 0.17% | 持有 | |
| 600.00K | $3.04M | 0.03% | 持有 | |
| 598.01K | $3.03M | 0.00% | 新进 | |
| 518.36K | $2.63M | 0.00% | 增持 | |
| 511.41K | $2.59M | 0.00% | 减持 | |
| 496.29K | $2.52M | 0.18% | 增持 | |
| 369.13K | $1.87M | 0.02% | 减持 | |
| 296.59K | $1.50M | 0.00% | 增持 | |
| 287.72K | $1.46M | 1.21% | 减持 | |
| 277.39K | $1.41M | 0.00% | 增持 |
新建仓(Q2 2026)
- Kalehua Capital Management LLC 1.79M 股 · $1.07M
- GEODE CAPITAL MANAGEMENT, LLC 1.18M 股 · $702.73K
- Curated Wealth Partners LLC 190.00K 股 · $185.39K
- Qube Research & Technologies Ltd 127.00K 股 · $75.79K
- HRT FINANCIAL LP 126.68K 股 · $75.00K
- Mariner, LLC 58.66K 股 · $35.00K
- Schonfeld Strategic Advisors LLC 50.88K 股 · $30.36K
- Alpha Wealth Funds, LLC 50.00K 股 · $29.89K
- Point72 Asset Management 37.28K 股 · $22.25K
- Cerity Partners LLC 29.23K 股 · $17.45K
- Y-Intercept (Hong Kong) Ltd 22.37K 股 · $13.35K
- Abel Hall, LLC 22.12K 股 · $13.20K
完全清仓(较上季)
- STATE STREET CORP 卖出 1.75M 股 · $1.37M
- VANGUARD PORTFOLIO MANAGEMENT LLC 卖出 569.23K 股 · $444.00K
- Nuveen, LLC 卖出 229.28K 股 · $178.84K
- Charles Schwab Investment Management 卖出 210.74K 股 · $164.38K
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 卖出 210.74K 股 · $164.38K
- BNY Mellon 卖出 193.53K 股 · $150.95K
- Deutsche Bank AG 卖出 103.33K 股 · $80.59K
- VICTORY CAPITAL MANAGEMENT INC 卖出 88.44K 股 · $68.98K
- ALLIANCEBERNSTEIN L.P. 卖出 64.48K 股 · $50.49K
- Redhawk Wealth Advisors, Inc. 卖出 49.15K 股 · $38.34K
- Invesco Ltd 卖出 46.35K 股 · $36.16K
- PRICE T ROWE ASSOCIATES INC /MD/ 卖出 46.13K 股 · $36.00K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. | 4.97M | 8.51M | 10.51M | 10.51M | 10.54M | 14.67M | 14.67M | 14.67M | 14.67M | 14.67M | 10.17M | 10.17M | 10.17M | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.76M | 3.81M | 3.81M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Kalehua Capital Management LLC | 1.83M | 1.79M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 1.78M | 2.47M | 14.71M | 14.70M | 14.70M | 13.35M | 12.89M | 12.10M | 11.37M | 10.35M | 8.92M | 8.78M | 8.56M | 8.14M | 7.97M | 4.35M | 4.29M | 4.21M | 4.17M | 4.17M |
| BlackRock Inc | 1.62M | 1.83M | 6.44M | 6.55M | 6.47M | 5.78M | 1.59M | 1.53M | 1.40M | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 1.21M | 1.18M | 2.39M | 2.28M | 2.18M | 2.10M | 927.80K | 891.41K | 809.10K | 662.68K | 595.11K | 587.00K | 587.00K | 593.47K | 578.90K | 242.24K | 239.50K | 238.81K | 234.32K | 231.50K |
| UBS Group AG | 1.17M | 1.53M | 3.87M | 1.63M | 4.51M | 1.75M | 1.64M | 229.58K | — | — | 20.19K | 16.43K | 4.40K | — | 1.00K | — | 5.97K | 2.00K | 4.00K | 1.13K |
| Morgan Stanley | 1.10M | 1.34M | 1.23M | 1.40M | 710.34K | 259.97K | 262.68K | 41.21K | 1 | 1 | 19.72K | 15.92K | 2.40K | 2.46K | 2.28K | — | — | — | 72 | 20.46K |
| VANGUARD FIDUCIARY TRUST CO | 576.12K | 576.12K | 651.83K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 481.95K | — | 1.75M | 1.72M | 4.20M | 1.24M | 367.31K | 300.51K | 168.31K | 168.31K | 166.81K | 166.81K | 166.81K | — | — | — | — | — | — | — |
| Squarepoint Ops LLC | 400.83K | — | — | — | 124.92K | — | 235.24K | 26.61K | 13.38K | — | — | 119.45K | 139.99K | — | — | — | — | — | — | — |
| Marshall Wace | 319.67K | 368.12K | 138.12K | — | — | 511.41K | 838.45K | — | 14.03K | — | 158.62K | — | — | — | 10.95K | 140.30K | 175.91K | 159.41K | 203.01K | 250.40K |
| Renaissance Technologies | 281.52K | 165.22K | 40.52K | — | — | 518.36K | 479.95K | 574.46K | 1.15M | 1.29M | 1.27M | 877.97K | 505.99K | 526.36K | 157.66K | 166.08K | 187.53K | 150.82K | 110.86K | 127.16K |
| StoneX Group Inc. | 105.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| LPL Financial LLC | 96.38K | 35.55K | 35.55K | 30.10K | — | 26.34K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BANK OF MONTREAL /CAN/ | 60.80K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| KINGSWOOD WEALTH ADVISORS, LLC | 52.00K | 52.00K | 52.00K | 52.00K | — | 36.00K | 37.00K | 47.00K | — | — | 60.00K | — | — | — | — | — | — | — | — | — |
| Alpha Wealth Funds, LLC | 50.00K | 50.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 48.11K | 127.00K | — | — | — | — | 414.59K | 430.02K | 139.16K | 188 | 9.64K | 188 | 188 | — | — | — | — | — | — | — |
| Hobbs Group Advisors, LLC | 35.99K | 35.99K | 19.42K | — | 18.65K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold ATYR?
As of 2026-Q2, 96 institutional funds reported holding ATYR (ATYR PHARMA INC) in SEC 13F filings, with a combined reported value of $23.57M.
How many shares of ATYR do institutions own?
13F filers reported 39.37M shares of ATYR, worth $23.57M in aggregate at the end of 2026-Q2.
Is institutional ownership of ATYR rising or falling?
Share counts moved -33.5% versus the prior quarter — distribution.
Who are the top institutional holders of ATYR?
The largest 13F holders are Octagon Capital Advisors LP, Rosalind Advisors, Inc., Alyeska Investment Group, L.P., Integral Health Asset Management, LLC, Vanguard Group; the top 25 are ranked at the top of this page.
Who are the major shareholders of ATYR PHARMA INC?
The major shareholders of ATYR PHARMA INC (ATYR) by reported 13F value are Octagon Capital Advisors LP, Rosalind Advisors, Inc., Alyeska Investment Group, L.P., Integral Health Asset Management, LLC, Vanguard Group, among 253 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.